Biovitrum AB
Patent Applications and Registrations
Patent applications and USPTO patent grants for Biovitrum AB.The latest application filed is for "inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1".
Company Profile
0.49.17
- Biovitrum AB - Stockholm SE
- Biovitrum AB - Amgen Inc.
- Biovitrum AB - SE SE
Patent Activity
| Patent | Date |
|---|---|
| Inhibitors of 11-.beta.-hydroxy steroid dehydrogenase type 1 Grant 8,686,011 - Henriksson , et al. April 1, 2 | 2014-04-01 |
| Inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 Grant 8,541,592 - Henriksson , et al. September 24, 2 | 2013-09-24 |
| Inhibitors Of 11-beta-hydroxy Steroid Dehydrogenase Type 1 App 20120010256 - HENRIKSSON; Martin ; et al. | 2012-01-12 |
| Benzofuran Compounds App 20110015185 - Johansson; Gary ; et al. | 2011-01-20 |
| Benzofuran compounds Grant 7,820,675 - Johansson , et al. October 26, 2 | 2010-10-26 |
| New Compounds App 20100222330 - Caldirola; Patrizia ; et al. | 2010-09-02 |
| Aryl sulfonamide compounds for treating obesity Grant 7,718,650 - Bremberg , et al. May 18, 2 | 2010-05-18 |
| Inhibitors Of 11-beta-hydroxy Steriod Dehydrogenase Type 1 App 20100113435 - BARF; Tjeerd ; et al. | 2010-05-06 |
| Use of cyclolignans and new cyclolignans Grant 7,709,526 - Larsson , et al. May 4, 2 | 2010-05-04 |
| Inhibitors of 11-.beta.-hydroxy steroid dehydrogenase type 1 Grant 7,671,051 - Barf , et al. March 2, 2 | 2010-03-02 |
| Substituted azole aromatic heterocycles as inhibitors of 11.beta.-HSD-1 Grant 7,666,888 - Bartberger , et al. February 23, 2 | 2010-02-23 |
| Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 Grant 7,618,961 - Barf , et al. November 17, 2 | 2009-11-17 |
| Compounds II App 20090281087 - Boyd; Joseph W. ; et al. | 2009-11-12 |
| Compounds IV App 20090203695 - Higginbottom; Michael ; et al. | 2009-08-13 |
| Substituted naphthalene sulfonamides Grant 7,572,787 - Caldirola , et al. August 11, 2 | 2009-08-11 |
| Substituted sulfonamide compounds useful for the prophylaxis and treatment of conditions relating to obesity, type II diabetes and/or disorders of the central nervous system Grant 7,566,715 - Bremberg , et al. July 28, 2 | 2009-07-28 |
| New compounds I App 20090181967 - Boyd; Joseph W. ; et al. | 2009-07-16 |
| New compounds III App 20090176798 - Boyd; Joseph W. ; et al. | 2009-07-09 |
| Certain arylaliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases Grant 7,534,794 - Nilsson , et al. May 19, 2 | 2009-05-19 |
| Therapeutic compounds App 20080076776 - Higginbottom; Michael ; et al. | 2008-03-27 |
| Compounds Grant 7,319,097 - Bremberg , et al. January 15, 2 | 2008-01-15 |
| Therapeutic compounds App 20080009461 - Savory; Edward D. | 2008-01-10 |
| Methods for identifying active compounds Grant 7,285,392 - Parrow , et al. October 23, 2 | 2007-10-23 |
| Inhibitors of 11-.beta.-hydroxy steroid dehydrogenase type 1 Grant 7,253,196 - Henriksson , et al. August 7, 2 | 2007-08-07 |
| Pyrimidine compounds and their use Grant 7,247,633 - Nilsson July 24, 2 | 2007-07-24 |
| Amino-substituted 1H-pyrazin-2-ones and 1H-quinoxalin-2-ones Grant 7,244,722 - Cernerud , et al. July 17, 2 | 2007-07-17 |
| Compounds and their use Grant 7,229,997 - Nilsson , et al. June 12, 2 | 2007-06-12 |
| Compounds, their use and preparation Grant 7,226,925 - Nilsson , et al. June 5, 2 | 2007-06-05 |
| Podophyllotoxin derivatives as igf-1r inhibitors App 20070123491 - Axelson; Magnus ; et al. | 2007-05-31 |
| Inhibitors of 11-.beta.-hydroxy steroid dehydrogenase type 1 Grant 7,173,030 - Pyring , et al. February 6, 2 | 2007-02-06 |
| Arylsulfonamide compounds Grant 7,173,035 - Bremberg , et al. February 6, 2 | 2007-02-06 |
| New compounds App 20070004765 - Graffner-Nordberg; Malin ; et al. | 2007-01-04 |
| Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 App 20060287374 - Barf; Tjeerd ; et al. | 2006-12-21 |
| Bicyclic sulfonamide compounds Grant 7,144,883 - Caldirola , et al. December 5, 2 | 2006-12-05 |
| Inhibitors of 11-.beta.-hydroxy steroid dehydrogenase type 1 Grant 7,132,436 - Kurz , et al. November 7, 2 | 2006-11-07 |
| Process for the preparation of stable acid addition salt of 2,3-disubstituted pyrazine compounds Grant 7,129,354 - Fleck, legal representative , et al. October 31, | 2006-10-31 |
| Inhibitors of 11-.beta.-hydroxy steroid dehydrogenase type 1 Grant 7,125,900 - Barf , et al. October 24, 2 | 2006-10-24 |
| Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 Grant 7,094,792 - Barf , et al. August 22, 2 | 2006-08-22 |
| Compounds, their use and preparation Grant 7,087,750 - Caldirola , et al. August 8, 2 | 2006-08-08 |
| Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 App 20060160797 - Nilsson; Marianne ; et al. | 2006-07-20 |
| Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 Grant 7,074,788 - Kurz , et al. July 11, 2 | 2006-07-11 |
| Certain arylaliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases Grant 7,071,180 - Nilsson , et al. July 4, 2 | 2006-07-04 |
| Promoter sequences Grant 7,045,294 - Abrahamsen , et al. May 16, 2 | 2006-05-16 |
| Inhibitors of 11-.beta.-hydroxy steroid dehydrogenase type 1 Grant 7,030,135 - Nilsson , et al. April 18, 2 | 2006-04-18 |
| Compounds Grant 6,969,710 - Bremberg , et al. November 29, 2 | 2005-11-29 |
| Inhibitors of 11-beta-hydroxy steriod dehydrogenase type 1 App 20050250776 - Barf, Tjeerd ; et al. | 2005-11-10 |
| Process for bulk autoclaving Grant 6,891,035 - Ljungquist May 10, 2 | 2005-05-10 |
| Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 App 20050009821 - Pyring, David ; et al. | 2005-01-13 |
| Pharmaceutical combination formulation and method of treatment with the combination Grant 6,818,639 - Sukhwinder , et al. November 16, 2 | 2004-11-16 |
| Device and method for dispensing at least two mutually reactive components Grant 6,773,414 - Ljungquist August 10, 2 | 2004-08-10 |
| Expression vector for production of recombinant proteins Grant 6,773,919 - Norstedt , et al. August 10, 2 | 2004-08-10 |
| Compounds and their use Grant 6,756,377 - Nilsson , et al. June 29, 2 | 2004-06-29 |
| Bacterial receptor structures Grant 6,740,734 - Nilsson , et al. May 25, 2 | 2004-05-25 |
| Promoter sequences Grant 6,723,553 - Abrahmsen , et al. April 20, 2 | 2004-04-20 |
| Animal model Grant 6,709,860 - Enerback , et al. March 23, 2 | 2004-03-23 |
| Dispenser for mixing then dispensing multiple components Grant 6,708,847 - Ljungquist March 23, 2 | 2004-03-23 |
| Receptor structures Grant 6,602,977 - Ljungqvist , et al. August 5, 2 | 2003-08-05 |
| Stable factor VIII compositions Grant 6,599,724 - Mikaelsson , et al. July 29, 2 | 2003-07-29 |
| Method and use Grant 6,573,291 - Gronberg , et al. June 3, 2 | 2003-06-03 |
| Method for purification of proteins App 20030083471 - Winge, Stefan | 2003-05-01 |
| Bacterial receptor structures Grant 6,534,628 - Nilsson , et al. March 18, 2 | 2003-03-18 |
| Response element Grant 6,472,515 - Climent-Johansson , et al. October 29, 2 | 2002-10-29 |
| Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases Grant 6,465,467 - Nilsson , et al. October 15, 2 | 2002-10-15 |
| Tissue treatment composition comprising fibrin or fibrinogen and biodegradable and biocompatible polymer Grant 6,440,427 - Wadstrom August 27, 2 | 2002-08-27 |
| Method of structure-based drug design using a crystalline form of activated trap Grant 6,403,330 - Uppenberg June 11, 2 | 2002-06-11 |
| Filtration Grant 6,399,357 - Winge June 4, 2 | 2002-06-04 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 